Palmoplantar Pustulosis Clinical Trials

37 clinical trials for Palmoplantar Pustulosis across international registries, including 11 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A phase 3, randomized, double-blind, placebo-controlled, multicenter study with open-label extension to evaluate the efficacy and safety of bimekizumab in study participants with palmoplantar pustulosis — RECRUITING · PHASE3
• A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis — RECRUITING · PHASE2
• A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar Pustulosis — RECRUITING · PHASE3
• Picankibart in Palmoplantar Pustulosis — RECRUITING · NA
• Clinical Observation of Xeligekimab in the Treatment of Moderate to Severe Palmoplantar Pustulosis — RECRUITING · PHASE4
• Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers — RECRUITING
• A Prospective, Single-arm, Open-label Clinical Trial to Evaluate the Efficacy and Safety of Ivarmacitinib in the Treatment of Palmoplantar Pustulosis — RECRUITING · NA
• A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY WITH OPEN-LABEL EXTENSION TO EVALUATE THE EFFICACY AND SAFETY OF BIMEKIZUMAB IN STUDY PARTICIPANTS WITH PALMOPLANTAR PUSTULOSIS — RECRUITING · PHASE3
• A PROOF-OF-CONCEPT PHASE 2A, DOUBLE-BLIND, 2-ARM TRIAL TO INVESTIGATE EFFICACY AND SAFETY OF TWICE DAILY DELGOCITINIB CREAM 20 MG/G COMPARED WITH CREAM VEHICLE DURING A 16-WEEK TREATMENT PERIOD IN ADULT SUBJECTS WITH MILD TO SEVERE PALMOPLANTAR PUSTULOSIS — RECRUITING · PHASE2
• A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE RANGING PHASE 2 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF RIST4721 IN SUBJECTS WITH PALMOPLANTAR PUSTULOSIS — RECRUITING · PHASE2
• MULTI-CENTER, DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED, PHASE IIB DOSE-FINDING STUDY TO EVALUATE EFFICACY AND SAFETY OF DIFFERENT SUBCUTANEOUS DOSES OF BI 655130 IN PATIENTS WITH MODERATE TO SEVERE PALMOPLANTAR PUSTULOSIS (PPP) — RECRUITING · PHASE2
• A Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study to Evaluate the Efficacy and Safety of RIST4721 in Subjects with Palmoplantar Pustulosis — COMPLETED · PHASE2
• Tofacitinib Plus Imatinib in Moderate-to-Severe Palmoplantar Pustulosis — NOT_YET_RECRUITING · PHASE3
• Deucravacitinib for the Treatment of Palmoplantar Pustulosis — TERMINATED · PHASE4
• Efficacy and Tolerability of Deucravacitinib in the Management of Palmoplantar Pustulosis — TERMINATED · NA
• Evaluating Legit.Health Plus Support for Improving Diagnosis of Generalized Pustular Psoriasis and Other Skin Conditions Among Primary Care Physicians and Dermatologists — COMPLETED
• A Registry Study of Palmoplantar Pustulosis (PPP) Treatment Patterns, Disease Burden and Treatment Outcomes in Japan — COMPLETED
• A Study to Test Long-term Treatment With Spesolimab in People With Palmoplantar Pustulosis (PPP) Who Took Part in Previous Studies With Spesolimab — TERMINATED · PHASE2
• A Study to Test How Effective and Safe Different Doses of BI 655130 Are in Patients With a Moderate to Severe Form of the Skin Disease Palmoplantar Pustulosis — COMPLETED · PHASE2
• A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in Adults With Palmoplantar Pustulosis — COMPLETED · PHASE2
• A Phase 2, multicentre open-label study to explore the effects of sonelokimab in patients with moderate-to-severe pustulosis palmoplantaris — OTHER · PHASE2
• Phase 3, Randomized Study of Apremilast in Japanese Participants With Palmoplantar Pustulosis (PPP) — COMPLETED · PHASE3
• An Efficacy and Safety of Guselkumab in Participants With Palmoplantar Pustulosis — COMPLETED · PHASE3
• Construction of a Psoriasis and Psoriatic Arthritis Diagnostic Model Based on Multidimensional Nail Information — NOT_YET_RECRUITING
• A Phase 2b Study to Evaluate RIST4721 in Palmoplantar Pustulosis (PPP) — TERMINATED · PHASE2
• Safety and Pharmacokinetics of Repeat Doses of CSL324 in Subjects With Hidradenitis Suppurativa and Palmoplantar Pustulosis — COMPLETED · PHASE1
• A Study of KHK4827 in Subjects With Palmoplantar Pustulosis — COMPLETED · PHASE3
• Study of Subcutaneous Risankizumab Injection to Assess Change in Palmoplantar Pustulosis Area and Severity Index [PPPASI] in Adult Japanese Participants With Palmoplantar Pustulosis — COMPLETED · PHASE3
• A Study to Evaluate RIST4721 in Palmoplantar Pustulosis (PPP) — COMPLETED · PHASE2
• Apremilast in Patients With Moderate to Severe Palmoplantar Pustulosis (PPP) (APLANTUS) — COMPLETED · PHASE2
• Anakinra for Inflammatory Pustular Skin Diseases — COMPLETED · PHASE2
• Palmoplantar Pustulosis and Generalized Pustular Psoriasis: A National Population-based Analysis of Prevalence — OTHER
• AN OPEN-LABEL, SINGLE ARM, LONG TERM TRIAL OF SPESOLIMAB TREATMENT IN PATIENTS WITH PALMOPLANTAR PUSTULOSIS (PPP) WHO HAVE COMPLETED PREVIOUS BI SPESOLIMAB TRIALS — COMPLETED
• A PHASE II, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, MULTIPLE DOSE STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ANB019 IN SUBJECTS WITH PALMOPLANTAR PUSTULOSIS — COMPLETED · PHASE2
• A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2A STUDY TO EVALUATE THE EFFICACY AND SAFETY OF RIST4721 IN SUBJECTS WITH PALMOPLANTAR PUSTULOSIS — COMPLETED · PHASE2
• MULTI-CENTER, DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED, PHASE IIA STUDY TO INVESTIGATE EFFICACY, SAFETY,TOLERABILITY, PHARMACOKINETICS AND PHARMACOGENOMICS OF MULTIPLE INTRAVENOUS DOSES OF BI 655130 IN PATIENTS WITH PALMOPLANTAR PUSTULOSIS (PPP) — COMPLETED · PHASE2
• Immune Signature of Palmoplantar Pustulosis — COMPLETED

Refine this search